POLE and cancer: While pathogenic exonuclease-domain variants are well established in cancer, biallelic <i>POLE1</i> variants remain largely unexplored in non-malignant human cells.<h4>Methods</h4>Here, we analyzed primary fibroblasts derived from a skin biopsy of a compound-heterozygous patient carrying two <i>POLE1</i> variants.